SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Injective taken over by the community.

Nonja

The community is actively discussing $NONJA as the leading meme coin on Injective Protocol ($INJ), which is attracting attention for its robust fundamentals, significant undervaluation, and the anticipated 'asymmetric upside' driven by potential staked ETFs and a proposed doubling of its deflation rate.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after FDA approval for BYSANTI in bipolar I disorder and schizophrenia, with its robust patent protection until 2044 igniting community excitement. Investors widely view the stock as undervalued, anticipating potential multi-billion dollar peak sales and a possible acquisition by big pharma looking to bolster pipelines against patent cliffs, especially considering the "mega blockbuster" potential of its Nereus asset for GLP-1 induced nausea.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

SWEAT CRYPTO is generating buzz with community members viewing its current low valuation as a prime buying opportunity, driven by sustained long-term optimism for its unique "move-to-earn" model that rewards users for physical activity and offers staking benefits.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Doubled token burns, a new staked ETF filing, and a $100M institutional investment to buy and stake its tokens are driving strong community excitement around Injective's fundamental undervaluation. Many are closely watching its potential for significant growth, with its associated meme coin $NONJA seen as a leveraged play.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is a trending topic amidst significant developments in its AI and cross-chain capabilities, highlighted by the growing adoption of its Intents solution for broader ecosystem interoperability and a notable increase in active users. While some express frustration with price volatility, a substantial part of the community is actively accumulating, seeing NEAR as an undervalued asset with strong potential driven by its foundational role in the evolving AI crypto landscape.

Ethereum Classic

Ethereum Classic is trending as the community debates its recent underperformance against broader crypto movements, with many accumulating on significant dips, driven by hopes for a robust altcoin season and potential regulatory clarity.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display Technologies, Specialty Materials, Environmental Technologies, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computer, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Environmental Technologies segment focuses on manufacturing ceramic substrates and filter products for emissions control in mobile applications. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

GLW is surging after securing a multi-year $6 billion deal with Meta to power its AI data centers with optical fiber, positioning Corning as a critical infrastructure provider in the accelerating AI buildout and sparking community discussions around its valuation and potential for more hyperscaler partnerships.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following a dual financing announcement, encompassing a dilutive public offering and a non-dilutive royalty agreement for its lead cancer therapy, CAN-2409. The community is actively debating the strategic implications of these moves, with some concerned about immediate dilution while others view the capital secured as critical validation and runway for advancing its promising clinical pipeline.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as the Supreme Court's decision to strike down prior "emergency" tariffs sparks debate over potential government refunds and reports of individuals with ties to the former administration possibly profiting significantly. The community is actively discussing the broader economic impact and the former President's immediate, defiant vow to implement new, wider tariffs through alternative legal avenues.

ARK 21Shares Bitcoin ETF - ARK 21Shares Bitcoin ETF Beneficial Interest

ARK 21Shares Bitcoin ETF

ARKB is trending amidst strong institutional inflows into Bitcoin ETFs, with the community actively debating the asset's price trajectory, especially with the halving event approaching, while also discussing the fund's recent share split.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TimesSquare Capital Management LLC Acquires 45,950 Shares of Guardian Pharmacy Services, Inc. $GRDN

TimesSquare Capital Management LLC grew its stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 5.6% in the 3rd quarter, according to its most recent filing with the Securities and...

New York State Common Retirement Fund Sells 347,524 Shares of Guardian Pharmacy Services, Inc. $GRDN

New York State Common Retirement Fund trimmed its holdings in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 98.9% in the third quarter, according to the company in its most...

Guardian Pharmacy Services, Inc. to Participate in Upcoming Raymond James Institutional Investor Conference

Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that the company will present at the Raymond James Institutional Investors Conference in Orlando, Florida on Monday, March 2 at 1:40 p.m...

Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call

Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release fourth quarter and full-year 2025 financial results after market close on Wednesday, March 11, 2026. Management will...

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Rating of "Moderate Buy" by Brokerages

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five brokerages that are presently covering the company, MarketBeat Ratings...

Short Interest in Guardian Pharmacy Services, Inc. (NYSE:GRDN) Rises By 33.3%

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) saw a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling...

Guardian Pharmacy Services (NYSE:GRDN) Shares Down 6.9% - Time to Sell?

Guardian Pharmacy Services (NYSE:GRDN) Shares Down 6.9% - Here's Why...

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) have earned an average rating of "Moderate Buy" from the five brokerages that are covering the stock, Marketbeat Ratings...

Implied Volatility Surging for Guardian Pharmacy Services Stock Options

Investors need to pay close attention to Guardian Pharmacy Services stock based on the movements in the options market lately.

Guardian Pharmacy Services (NYSE:GRDN) Trading Down 0.8% - Should You Sell?

Guardian Pharmacy Services (NYSE:GRDN) Stock Price Down 0.8% - Time to Sell...

Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.

Current Price	$33.54
Prev Close	$33.04
Open	$32.93
Dividend Yield	0.00%
50-Day Moving Average	$31.05
Beta	0.77
Avg. Volume	272,620.10
PE Ratio	51.91

52-Week High	$37.43
52-Week Low	$17.78
Market Capitalization	$2.09B
EPS (Annual)	-$1.74
Price to Book	11.39
Revenue Per Employee	$361,296.77

GRDN
Guardian Pharmacy Services Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GRDN News

GRDNGuardian Pharmacy Services Inc